Clinical trial
Trial of RAD001 in Patients With Operable Non-Small Cell Lung Cancer (NSCLC)
NCT00401778 is registered in ClinicalTrials.gov with Emory University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Trial of RAD001 in Patients With Operable Non-Small Cell Lung Cancer (NSCLC)
- Lead sponsor
- Emory University
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- November 30, 2006
- Completion date
- December 31, 2013
- Enrollment
- 33 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
lung cancer